1. An oral fixed-dose combination of decitabine and cedazuridine in myelodysplastic syndromes: a multicentre, open-label, dose-escalation, phase 1 study. Issue 4 (April 2019) Authors: Savona, Michael R; Odenike, Olatoyosi; Amrein, Philip C; Steensma, David P; DeZern, Amy E; Michaelis, Laura C; Faderl, Stefan; Harb, Wael; Kantarjian, Hagop; Lowder, James; Oganesian, Aram; Azab, Mohammad; Garcia-Manero, Guillermo Journal: Lancet Issue: Volume 6:Issue 4(2019) Page Start: e194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessing clonal haematopoiesis: clinical burdens and benefits of diagnosing myelodysplastic syndrome precursor states. Issue 1 (January 2020) Authors: Gondek, Lukasz P; DeZern, Amy E Journal: Lancet Issue: Volume 7:Issue 1(2020) Page Start: e73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial. Issue 9 (September 2022) Authors: DeZern, Amy E; Eapen, Mary; Wu, Juan; Talano, Julie-An; Solh, Melhem; Dávila Saldaña, Blachy J; Karanes, Chatchada; Horwitz, Mitchell E; Mallhi, Kanwaldeep; Arai, Sally; Farhadfar, Nosha; Hexner, Elizabeth; Westervelt, Peter; Antin, Joseph H; Deeg, H Joachim; Leifer, Eric; Brodsky, Robert A; Loga... Journal: Lancet Issue: Volume 9:Issue 9(2022) Page Start: e660 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Myelodysplastic syndrome and autoimmune disorders: two sides of the same coin?. Issue 7 (July 2022) Authors: Hochman, Michael J; DeZern, Amy E Journal: Lancet Issue: Volume 9:Issue 7(2022) Page Start: e523 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. On the basis of sex: outcomes in myelodysplastic syndromes. Issue 2 (February 2023) Authors: Hochman, Michael J; DeZern, Amy E Journal: Lancet Issue: Volume 10:Issue 2(2023) Page Start: e83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Single-Nucleotide Polymorphism Leading to False Allelic Fraction by Droplet Digital PCR. (6th January 2020) Authors: Christenson, Eric S; Dalton, W Brian; Chu, David; Waters, Ian; Cravero, Karen; Zabransky, Daniel J; DeZern, Amy E; Park, Ben H o Journal: Clinical chemistry Issue: Volume 63:Number 8(2017) Page Start: 1370 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Sotatercept with long-term extension for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes: a phase 2, dose-ranging trial. Issue 2 (February 2018) Authors: Komrokji, Rami; Garcia-Manero, Guillermo; Ades, Lionel; Prebet, Thomas; Steensma, David P; Jurcic, Joseph G; Sekeres, Mikkael A; Berdeja, Jesus; Savona, Michael R; Beyne-Rauzy, Odile; Stamatoullas, Aspasia; DeZern, Amy E; Delaunay, Jacques; Borthakur, Gautam; Rifkin, Robert; Boyd, Thomas E; Laade... Journal: Lancet Issue: Volume 5:Issue 2(2018) Page Start: e63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗